Scientists have used AI to identify two novel subtypes of multiple sclerosis (MS), which could offer new, targeted treatments ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

Kesimpta is a medication used to treat relapsing forms of multiple sclerosis (MS) and clinically isolated syndrome (CIS). Kesimpta comes as a solution inside single-dose prefilled injection pens or ...

Susie Wyss used to inject herself daily with a medication for multiple sclerosis. “The injection hurt. It caused welts, bruises, and sometimes permanent lipoatrophy,” Wyss told more than 800 people ...

A new trial will test whether a jab to protect against a common virus found in almost all people with multiple sclerosis (MS) could treat the condition. Scientists believe that targeting the ...

Living with multiple sclerosis (MS) often means dealing with different kinds of pain — some caused by damage to nerves, some by muscle stiffness or spasms, and some related to changes in how the body ...

Biostate AI, a leading innovator in artificial intelligence for RNA sequencing, today announced a strategic partnership with the Accelerated Cure Project (ACP), a nonprofit organization dedicated to ...

Multiple sclerosis (MS) is best known for the physical symptoms it can cause, such as numbness, weakness, spasticity, and difficulty walking. But this autoimmune disease of the central nervous system ...

How fast can your team pull a 7,500-pound tractor 20 yards? On June 1, the National Multiple Sclerosis (MS) Society, New Jersey Metro chapter will welcome teams of up to six people to Pull for a Cure ...